Lawrence Karsh, MD, FACS
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:Genetech/HoffmanMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:MedivationMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:GenomeDx BIosciencesMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Specialty Not Specified)Ineligible company:BioXcelMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Specialty Not Specified)Ineligible company:HinovaMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:CUSPMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:UROGPOMitigation strategy:Peer reviewDate reviewed:09/20/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:UrogenMitigation strategy:Peer reviewDate reviewed:09/20/2022